0.34
price down icon4.25%   -0.0151
after-market Handel nachbörslich: .36 0.02 +5.88%
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
2.15%
-18.05
-18.45 -28.67 -25.39 -35.88
Income/Loss From Continuing Operations Before Tax
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Income/Loss From Continuing Operations After Tax
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Net Income/Loss
0.28%
-16.71
-16.76 -27.11 -23.86 -34.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
123.56K%
56.30
0.0455 54.79 54.68 54.62
Diluted Average Shares
123.56K%
56.30
0.0455 54.79 54.68 54.62
Basic Earnings Per Share
0.00%
-0.30
-0.30 -0.49 -0.44 -0.63
Diluted Earnings Per Share
0.00%
-0.30
-0.30 -0.49 -0.44 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):